Literature DB >> 15856365

West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis.

John A Batsis1, Michael P Phy.   

Abstract

The clinical presentation of West Nile virus (WNV) can be severe in immunosuppressed patients. A 65-year-old with steroid-dependent rheumatoid arthritis on infliximab and methotrexate presented with meningitis and profound muscular weakness. Serum WNV IgM and IgG antibody were positive. WNV should be included in the differential diagnosis of neurological symptoms in peak months.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15856365     DOI： 10.1007/s10067-005-1085-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   3.650


  8 in total

1.  Outbreak of West Nile-like viral encephalitis--New York, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-10-01       Impact factor: 17.586

2.  The outbreak of West Nile virus infection in the New York City area in 1999.

Authors:  D Nash; F Mostashari; A Fine; J Miller; D O'Leary; K Murray; A Huang; A Rosenberg; A Greenberg; M Sherman; S Wong; M Layton
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

3.  Determination of human IgG and IgM class antibodies to West Nile virus by enzyme linked immunosorbent assay (ELISA).

Authors:  S Feinstein; Y Akov; B E Lachmi; S Lehrer; L Rannon; D Katz
Journal:  J Med Virol       Date:  1985-09       Impact factor: 2.327

4.  Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis.

Authors:  A F Kolb; L Pewe; J Webster; S Perlman; C B Whitelaw; S G Siddell
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion--Michigan, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-10-04       Impact factor: 17.586

Review 6.  West Nile virus: a primer for the clinician.

Authors:  Lyle R Petersen; Anthony A Marfin
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

7.  West Nile encephalitis in Israel, 1999: the New York connection.

Authors:  M Giladi; E Metzkor-Cotter; D A Martin; Y Siegman-Igra; A D Korczyn; R Rosso; S A Berger; G L Campbell; R S Lanciotti
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

8.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103
  8 in total
  3 in total

1.  Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection.

Authors:  Derek Trobaugh; Sharone Green
Journal:  Curr Trop Med Rep       Date:  2015-03-01

2.  Bacterial meningitis associated with infliximab.

Authors:  Raymond Farah; Svetlana Lisitsin; Moshe Shay
Journal:  Pharm World Sci       Date:  2006-09-27

3.  West Nile Virus Infection in the Immunocompromised Patient.

Authors:  Marilyn E Levi
Journal:  Curr Infect Dis Rep       Date:  2013-11-15       Impact factor: 3.663
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.